Drug class in one race
c-Abl drugs for Parkinson's Disease
2 tracked c-Abl drugs in the Parkinson's Disease race. The class explanation lives on the c-Abl page; the full indication pipeline across every mechanism is on the Parkinson's Disease page.
1 Phase 21 Phase 1
Head-to-head evidence: FB-101 vs Risvodetinib (IkT-148009)